Mereo BioPharma and OncoMed propose merger
The UK’s Mereo BioPharma is planning to merge with US group OncoMed Pharmaceuticals.
Read More
Tag: Oncomed
Celgene walks away from Oncomed’s navicixizumab
Celgene has decided not to exercise its option to license OncoMed’s bispecific antibody navicixizumab.
Read More
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
